Reversal of warfarin anticoagulation for urgent surgical procedures. - Wikidata - awgldk - TriplyDB

Reversal of warfarin anticoagulation for urgent surgical procedures.

Reversal of warfarin anticoagulation for urgent surgical procedures.

http://www.wikidata.org/entity/Q33421728

about

Cardiac tachyarrhythmias and anaesthesia: General principles and focus on atrial fibrillation.Management of anticoagulation in hip fractures: A pragmatic approach.

P2860

Q42363989-0E29AFEC-CAB8-47E3-83D3-C80CE60B0F7A Q51788589-494908AE-5563-4C64-B1DC-C63F11286760

P2860

Reversal of warfarin anticoagulation for urgent surgical procedures.

http://www.wikidata.org/entity/Q33421728

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Reversal of warfarin anticoagulation for urgent surgical procedures.

@ast

Reversal of warfarin anticoagulation for urgent surgical procedures.

@en

type

label

Reversal of warfarin anticoagulation for urgent surgical procedures.

@ast

Reversal of warfarin anticoagulation for urgent surgical procedures.

@en

prefLabel

Reversal of warfarin anticoagulation for urgent surgical procedures.

@ast

Reversal of warfarin anticoagulation for urgent surgical procedures.

@en

P1433

Q33421728-CCB7A974-B38D-4341-BF83-E0921B4C7E07

P1476

Q33421728-A392A64D-9FA5-4786-B8CE-3B27C8203417

P2093

Q33421728-0A9A7713-4753-4330-BD33-840F43F6E861

Q33421728-7DEEE67D-2708-4FD7-89CC-62766A7A3BDB

Q33421728-BDE4FBCB-B06F-4654-A8F9-88D52CDDBDA4

P2860

Q33421728-2033C0AB-80A2-4D22-845D-D68401F29956

Q33421728-232A4377-55E4-4C7E-A70C-C9BBBA16A3A2

Q33421728-25A0550B-6E68-43D1-9032-B63F3BD04258

Q33421728-387D8009-D36A-43A9-AB44-CED9BB15A8EC

Q33421728-392251A1-0807-44A1-9CAF-AF03089D9CCB

Q33421728-45A8F170-1323-4024-B648-BE36E80D8B86

Q33421728-48A1F708-EF58-4D69-89B1-C877772A9100

Q33421728-4B586C14-AF29-43C5-B9FB-DBA6458146F8

Q33421728-813EB5A1-7D34-45A4-8BDC-0D74E0B261CA

Q33421728-8CEEF3EF-BEE7-4BFF-B789-CDFA99A819B5

P2888

Q33421728-7C2579A7-72E6-42B7-BE0A-F7EB53935F06

P304

Q33421728-F3697A5F-E72D-4C6B-B42E-F54CA0EC8448

P31

Q33421728-23596A27-7734-412D-992D-559D692207ED

P356

Q33421728-05B7817A-CD21-48EA-A0CC-0FBF5F3B8264

P433

Q33421728-11CD9CAE-2255-4502-8CB4-76DC579AC40D

P478

Q33421728-9274B17D-C305-4D27-985E-3588DDC6AD73

P577

Q33421728-97CC4B3A-27A1-45B2-B88C-30493E1DFE6D

P6179

Q33421728-189DD5E4-5F12-4EF5-AE72-EA732A5DB916

P698

Q33421728-EAB15A4B-8BEB-4C19-AFD3-58AF0C7E9608

P921

Q33421728-D6DD543A-FCCF-4ECE-925A-87A50D1FA7E8

P356

S12630-015-0366-3

P1433

Canadian Journal of Anaesthesia

P1476

Reversal of warfarin anticoagulation for urgent surgical procedures.

@en

P2093

Alexandra Schweitzer

http://www.w3.org/2001/XMLSchema#string

Janet van Vlymen

http://www.w3.org/2001/XMLSchema#string

Rachel Curtis

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Guidelines on oral anticoagulation with warfarin - fourth edition

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study.

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Anaphylactoid reactions to vitamin K.

Emergency reversal of warfarin anticoagulation.

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis.

P2888

s12630-015-0366-3

P304

634-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12630-015-0366-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037215911

http://www.w3.org/2001/XMLSchema#string

P698

25846343

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation